South Street Advisors LLC Merck & Co., Inc. Transaction History

South Street Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$123.8 - $132.96 $61,900 - $66,480	-500 Reduced 9.37%	4,837 $598,000
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $73,606 - $85,767	650 Added 13.87%	5,337 $704,000
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $107,198 - $116,841	987 Added 26.68%	4,687 $540,000
Q2 2021 Aug 05, 2021	SELL	$70.31 - $77.77 $331,863 - $367,074	-4,720 Reduced 56.06%	3,700 $288,000
Q1 2021 May 10, 2021	BUY	$68.86 - $81.11 $10,329 - $12,166	150 Added 1.81%	8,420 $649,000
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $15,789 - $17,523	220 Added 2.73%	8,270 $676,000
Q3 2020 Oct 26, 2020	BUY	$73.18 - $82.95 $16,831 - $19,078	230 Added 2.94%	8,050 $668,000
Q2 2020 Aug 04, 2020	BUY	$70.42 - $80.13 $310,552 - $353,373	4,410 Added 129.33%	7,820 $605,000
Q4 2019 Feb 07, 2020	SELL	$77.58 - $87.54 $54,306 - $61,278	-700 Reduced 17.03%	3,410 $310,000
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $312,688 - $340,842	4,110 New	4,110 $346,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $257B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of South Street Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on South Street Advisors LLC with notifications on news.